Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model
Autor: | Kuryk, Lukasz, Mathlouthi, Sara, Wieczorek, Magdalena, Gad, Beata, Rinner, Beate, Malfanti, Alessio, Mastrotto, Francesca, Salmaso, Stefano, Caliceti, Paolo, Garofalo, Mariangela |
---|---|
Zdroj: | In European Journal of Pharmaceutics and Biopharmaceutics June 2024 199 |
Databáze: | ScienceDirect |
Externí odkaz: |